163 related articles for article (PubMed ID: 27272258)
1. Introduction of d-Glutamate at a Critical Residue of Aβ42 Stabilizes a Prefibrillary Aggregate with Enhanced Toxicity.
Warner CJ; Dutta S; Foley AR; Raskatov JA
Chemistry; 2016 Aug; 22(34):11967-70. PubMed ID: 27272258
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403
[TBL] [Abstract][Full Text] [Related]
3. Internalisation and toxicity of amyloid-β 1-42 are influenced by its conformation and assembly state rather than size.
Vadukul DM; Maina M; Franklin H; Nardecchia A; Serpell LC; Marshall KE
FEBS Lett; 2020 Nov; 594(21):3490-3503. PubMed ID: 32871611
[TBL] [Abstract][Full Text] [Related]
4. Biophysical characterization of Abeta42 C-terminal fragments: inhibitors of Abeta42 neurotoxicity.
Li H; Monien BH; Fradinger EA; Urbanc B; Bitan G
Biochemistry; 2010 Feb; 49(6):1259-67. PubMed ID: 20050679
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
Miyamae Y; Kurisu M; Murakami K; Han J; Isoda H; Irie K; Shigemori H
Bioorg Med Chem; 2012 Oct; 20(19):5844-9. PubMed ID: 22921742
[TBL] [Abstract][Full Text] [Related]
6. Sclerotiorin Stabilizes the Assembly of Nonfibrillar Abeta42 Oligomers with Low Toxicity, Seeding Activity, and Beta-sheet Content.
Wiglenda T; Groenke N; Hoffmann W; Manz C; Diez L; Buntru A; Brusendorf L; Neuendorf N; Schnoegl S; Haenig C; Schmieder P; Pagel K; Wanker EE
J Mol Biol; 2020 Mar; 432(7):2080-2098. PubMed ID: 32061932
[TBL] [Abstract][Full Text] [Related]
7. The toxic conformation of the 42-residue amyloid beta peptide and its relevance to oxidative stress in Alzheimer's disease.
Irie K; Murakami K; Masuda Y; Morimoto A; Ohigashi H; Hara H; Ohashi R; Takegoshi K; Fukuda H; Nagao M; Shimizu T; Shirasawa T
Mini Rev Med Chem; 2007 Oct; 7(10):1001-8. PubMed ID: 17979802
[TBL] [Abstract][Full Text] [Related]
8. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement.
Morimoto A; Irie K; Murakami K; Masuda Y; Ohigashi H; Nagao M; Fukuda H; Shimizu T; Shirasawa T
J Biol Chem; 2004 Dec; 279(50):52781-8. PubMed ID: 15459202
[TBL] [Abstract][Full Text] [Related]
10. C-terminal peptides coassemble into Abeta42 oligomers and protect neurons against Abeta42-induced neurotoxicity.
Fradinger EA; Monien BH; Urbanc B; Lomakin A; Tan M; Li H; Spring SM; Condron MM; Cruz L; Xie CW; Benedek GB; Bitan G
Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14175-80. PubMed ID: 18779585
[TBL] [Abstract][Full Text] [Related]
11. Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species.
Jan A; Adolfsson O; Allaman I; Buccarello AL; Magistretti PJ; Pfeifer A; Muhs A; Lashuel HA
J Biol Chem; 2011 Mar; 286(10):8585-8596. PubMed ID: 21156804
[TBL] [Abstract][Full Text] [Related]
12. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
[TBL] [Abstract][Full Text] [Related]
13. Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42.
Weiffert T; Meisl G; Flagmeier P; De S; Dunning CJR; Frohm B; Zetterberg H; Blennow K; Portelius E; Klenerman D; Dobson CM; Knowles TPJ; Linse S
ACS Chem Neurosci; 2019 May; 10(5):2374-2384. PubMed ID: 30793584
[TBL] [Abstract][Full Text] [Related]
14. An azobenzene photoswitch sheds light on turn nucleation in amyloid-β self-assembly.
Doran TM; Anderson EA; Latchney SE; Opanashuk LA; Nilsson BL
ACS Chem Neurosci; 2012 Mar; 3(3):211-20. PubMed ID: 22860190
[TBL] [Abstract][Full Text] [Related]
15. d-Enantiomeric RTHLVFFARK-NH
Liu W; Dong X; Sun Y
ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
[TBL] [Abstract][Full Text] [Related]
16. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
17. Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide.
Rezaei-Ghaleh N; Andreetto E; Yan LM; Kapurniotu A; Zweckstetter M
PLoS One; 2011; 6(5):e20289. PubMed ID: 21633500
[TBL] [Abstract][Full Text] [Related]
18. α-synuclein-assisted oligomerization of β-amyloid (1-42).
Chau E; Kim JR
Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
[TBL] [Abstract][Full Text] [Related]
19. Stability of transmembrane amyloid β-peptide and membrane integrity tested by molecular modeling of site-specific Aβ42 mutations.
Poojari C; Strodel B
PLoS One; 2013; 8(11):e78399. PubMed ID: 24244308
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
